Wordt geladen...
Putting Proteomics Into Immunotherapy for Glioblastoma
In glioblastoma, the most aggressive brain cancer, a complex microenvironment of heterogeneity and immunosuppression, are considerable hurdles to classify the subtypes and promote treatment progression. Treatments for glioblastoma are similar to standard therapies for many other cancers and do not e...
Bewaard in:
| Gepubliceerd in: | Front Immunol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7940695/ https://ncbi.nlm.nih.gov/pubmed/33708196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.593255 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|